Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 7Thoracic 1Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Head & Neck 1Breast 1

Conditions

Breast Neoplasms 2Sleep Initiation and Maintenance Disorders 1Prostatic Neoplasms 1Fatigue 1

Interventions

Therapeutics 15Exercise 10Yoga 9Psychiatric Rehabilitation 8Mental Status and Dementia Tests 4Early Intervention, Educational 4Acupuncture Therapy 4Walking 3Surveys and Questionnaires 3Educational Status 3Control Groups 3Ultraviolet Therapy 2Transcranial Direct Current Stimulation 2Standard of Care 2Saline Solution 2Resistance Training 2Physical Therapy Modalities 2Music Therapy 2Methods 2Gene Expression Profiling 2Exercise Therapy 2Exercise Movement Techniques 2Enzyme-Linked Immunosorbent Assay 2Drug Therapy 2stinging nettle lectin 1reparixin 1peppermint oil 1methyl hydroxyethyl cellulose 1exemestane 1coenzyme Q10 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fatigue × Modafinil × Breast × Clear all
NCT01091974 2017-02-09

Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy

University of Rochester

Phase 2 Completed
138 enrolled 10 charts
Breast

Breast Neoplasms, Fatigue, Sleep Initiation and Maintenance Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡